Hear from key stakeholders and industry leaders including:

  • Vadim Drobin, M.D., M.P.H.
    Asthma Control Epidemiologist
    Pennsylvania Department of Health
  • Bruce Sunstein
    Founder and Partner
    Sunstein Kann Murphy & Timbers LLP
  • Kilty Iain
    COPD Disease Area Lead
    Pfizer Ltd
  • Stefan Leiner
    CMC-Expert
    Boehringer Ingelheim
  • Hongshi Yu, PhD
    Research Fellow
    Merck & Co.

Novel Discoveries and Treatment Programs Within the Respiratory Drug Arena

Asthma affects an estimated 235 million people globally, and as that number grows, so does the demand for drugs to cope with the illness.

GlobalData, a London-based research firm, says the global asthma market will expand from around $12.4 billion in 2009 to $14 billion by 2017.

Its November 2010 report stated that “competition in the asthma market is becoming intense” as a result of the emergence of new treatment options. In fact, GlobalData identified no fewer than 229 molecules in the pharmaceutical pipeline in development against asthma.

The 3rd Asthma & COPD provides you with an opportunity to take control of the market by improving competitiveness through targeted delivery to increase bioavailability of therapeutics and reduce the attrition rate. Here you will also gain insight into reformulating approved drugs as patents expire.

At the 3rd Asthma & COPD conference you will learn:

  • Case study examples of successful initiatives
  • To create a well balanced treatment program
  • The effective use of biomarkers within respiratory drug discovery
  • Emerging treatment paradigms within COPD drug development
  • To investigate new prevention programs to promote education and reduce prevalence of asthma and COPD

Those in attendance that you will network with include:

Stakeholders from all aspects of asthma and COPD, including Directors, Heads, Scientists, Research Leaders and Mangersworking in:

  • Respiratory Therapeutics
  • Research and Development
  • Inflammation
  • Clinical Development
  • Regulatory Affairs
  • Pulmonology
  • Drug Discovery
  • Treatment and Prevention
  • Clean Air and Environmental
  • Allergy Therapeutics
  • Preclinical Development

Testimonials

Past attendees say IQPC Pharma events are:

One of the best conferences I have attended
QA Associate Director, Johnson & Johnson
Timely presentations and points raised.
R&D Information Systems Director, Allergan
Sponsored by Sponsored by
MXM_LG_ENG_FL aerocrine
Media Partners
_media

[ Register Now ]